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ABSTRACT The Ca2+ currents, charge movements, and intracellular Ca2+ transients in mouse skeletal muscle cells
homozygous for a null mutation in the cchbl gene encoding the 131 subunit of the dihydropyridine receptor have been
characterized. /p3nul, the L-type Ca2+ current of mutant cells, had a -1 3-fold lower density than the L-type current of normal
cells (0.41 ± 0.042 pA/pF at +20 mV, compared with 5.2 ± 0.38 pA/pF in normal cells). /pnuii was sensitive to dihydropyridines
and had faster kinetics of activation and slower kinetics of inactivation than the L-type current of normal cells. Charge
movement was reduced -2.8-fold, with Qma, = 6.9 ± 0.61 and Qmax = 2.5 ± 0.2 nC/,uF in normal and mutant cells,
respectively. Approximately 40% of Qmax was nifedipine sensitive in both groups. In contrast to normal cells, Ca2+ transients
could not be detected in mutant cells at any test potential; however, caffeine induced a robust Ca2+ transient. In homoge-
nates of mutant muscle, the maximum density of [3H]PN200-1 10 binding sites (Bmj) was reduced -3.9-fold. The results
suggest that the excitation-contraction uncoupling of , -null skeletal muscle involves a failure of the transduction mechanism
that is due to either a reduced amount of a,s subunits in the membrane or the specific absence of B1j from the voltage-sensor
complex.
INTRODUCTION
The dihydropyridine (DHP) receptor complex of skeletal
muscle comprises four subunits: als, PI, a2/5, and y. This
complex serves as a voltage sensor during excitation-con-
traction (E-C) coupling and is responsible for the L-type
Ca2+ current. The a, subunit of the DHP receptor contains
the basic functional elements of the L-type Ca2+ channel,
which include a selectivity filter, a voltage sensor, and
binding sites for DHPs. The 13 subunit is located intracel-
lularly, and, in skeletal muscle, P3 consists of 524 amino
acids (Ruth et al., 1989). Transcripts from three additional
genes encoding ,B subunits have been reported (Hullin et al.,
1992; Castellano et al., 1993). Alternate splicing of the
primary PI gene (cchbl) transcript produces at least three
isoforms. One (Pl3a) is expressed exclusively in skeletal
muscle, whereas the other two (P3lb, j31c) are expressed in
brain, heart, and spleen (Powers et al., 1992).
The L-type Ca2+ current generated by interactions be-
tween specific subunits has been studied with a variety of
heterologous expression systems (for a review, see Hof-
mann et al., 1994). Coexpression of the f3, subunit with
either cardiac (aic) or skeletal (als) al subunits produces
an increase in L-type Ca2+ current density (Singer et al.,
1991; Wei et al., 1991; Itagaki et al., 1992; Lory et al., 1992,
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1993; Nishimura et al., 1993; Perez-Garcia et al., 1995;
Josephson and Varadi, 1996; Kamp et al., 1996), an increase
in the inactivation rate (Singer et al., 1991; Varadi et al.,
1991; Lory et al., 1993; Stea et al., 1993; De Waard et al.,
1994; Perez-Garcia et al., 1995), an increase in maximum
DHP binding site density (Lacerda et al., 1991; Varadi et al.,
1991; Wei et al., 1991; Lory et al., 1992; Nishimura et al.,
1993; Perez-Garcia et al., 1995), and a decrease in Ca2+
current sensitivity to Bay K 8644 (Singer et al., 1991;
Varadi et al., 1991; Itagaki et al., 1992; Lory et al., 1992).
The effect on the activation rate and the DHP binding
affinity varies, depending on the expression system. Some
investigators found an increase in the activation rate (Lac-
erda et al., 1991; Singer et al., 1991; Varadi et al., 1991;
Wei et aL, 1991; Lory et al., 1992); however, others found
no effect (Itagaki et al., 1992; Lory et al., 1993) or even a
decrease in the activation rate (Perez-Garcia et al., 1995).
Further, some investigators found an increase in DHP bind-
ing site affinity (Mitterdorfer et al., 1994), whereas the
others found no change (Lacerda et al., 1991; Varadi et al.,
199 1; Perez-Garcia et al., 1995). Whether 3 l modulates a I s
function in muscle cells in a manner that is analogous to the
findings in heterologous systems is unknown.
In recent years, the role of al subunits in E-C coupling
has been established by the use of dysgenic mice charac-
terized by the absence of the als and the absence of E-C
coupling (Tanabe et al., 1988, 1990a,b; Adams et al., 1990).
Expression studies in dysgenic skeletal muscle cells dem-
onstrated the importance of the cytoplasmic loop between
repeats II and III of als for skeletal-type E-C coupling
(Tanabe et al., 1990a). To determine the specific roles of 13,
in skeletal-type E-C coupling and the modulation in this
tissue of the L-type Ca2+ current by 8,, Gregg et al. (1995,
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1996) used gene targeting to inactivate the murine f3 gene
(cchbl). Mice heterozygous (cchbJ+1') for the mutation
develop normally. Mice homozygous (cchbl- -) for the
mutation die from asphyxia at birth because of the lack of
E-C coupling in skeletal muscles. In the present study we
characterized Ca21 currents, intramembrane charge move-
ments, and intracellular Ca2+ transients in 613-null myo-
tubes. Part of this research appeared previously in abstract
form (Strube et al., 1995, 1996; Beurg et al., 1996).
MATERIAL AND METHODS
Single-cell preparation
All experiments were performed on freshly isolated intercostal myotubes
from 18-day-old mouse fetuses. Homozygotes (cchbl-'-) for the mutation
are hereafter called mutant or 83,-null (Gregg et al., 1996). Fetuses with a
normal phenotype, hereafter called normal, were either heterozygotes
(cchbl'-) or wild type (+/+). Normal fetuses were usually littermates of
the mutant fetuses. The ages of fetuses were determined by defining day 0
of pregnancy as that of the appearance of the vaginal plug. Pregnant mice
were sacrificed by cervical dislocation, and the fetuses by decapitation.
Mutant fetuses were recognized by the curvature of the spine and the
absence of movement. The two half rib cages of each fetus were dissected
in normal Krebs solution containing (in mM) 136 NaCl, 5 KCI, 2 CaCl2,
1 MgCl2, 10 HEPES-NaOH; pH 7.4. The tissues were incubated at 37°C
for approximately 10 min in phosphate buffer saline (Sigma Chemical Co.,
St. Louis, MO) containing collagenase (3 mg/ml, Type I; Sigma) and
trypsin (1 mg/ml, Type III; Sigma). Myotubes were then mechanically
dispersed and collected in plastic culture dishes (35 mm diameter) con-
taining Krebs solution. Cells were maintained for approximately 2 h in
Krebs solution before the experiments were performed. The bottom of the
plastic dish was replaced by a thin glass coverslip for optical measurements.
Ca2+ current and charge movement
The standard patch-clamp technique was used in the whole-cell recording
configuration. The external solution for current recording was (in mM) 130
TEA methanesulfonate, 10 BaCl2 (or CaCl2), 1 MgCI2, 10-3 tetrodotoxin,
10 HEPES-TEA(OH); pH 7.4. The pipette solution consisted of (in mM)
140 Cs aspartate, 5 MgCl2, 5 EGTA, 10 MOPS-CsOH pH 7.2. Standard
patch electrodes were pulled from borosilicate glass and had tip resistance
of 2-5 Mfl when they were filled with pipette solution. Recordings were
made with an Axopatch ID patch clamp and a headstage with a 50-Mfl
feedback resistor (Axon Instruments, Foster City, CA). The recording
chamber was mounted upon the stage of an inverted microscope for
simultaneous measurement of cell fluorescence when appropriate. Junction
potentials were nulled before seal formation. Seal resistance in cell-at-
tached configuration varied from 0.5 to 5 Gfl. Cell capacitance was
determined by integration of an uncompensated capacitive transient elic-
ited by a 10-mV depolarizing pulse from a holding potential of -50 mV.
Effective series resistance was estimated as described (Armstrong and
Gilly, 1992) and was compensated up to the point of amplifier oscillation
with the analog circuit provided by Axopatch. Three linear capacitive
components and a leak component were canceled with a tunable analog
circuit kindly provided by J. Vergara. Linearity of the analog compensation
and pulse protocol in the range of -100 mV to + 100 mV was verified with
an RC cell model circuit. The data were filtered at 1-3 kHz and digitized
at 50-100 ,zs. Data acquisition was performed with a TL1 DMA interface
controlled by pCLAMP software (Axon Instrument). Current and charge
movements from each cell were normalized to the uncompensated cell
capacitance. All experiments were perforned at room temperature.
For recordings of charge movement, the bath solution was supple-
mented with 0.5 mM CdCl2 to block the ionic Ba21 currents. Determina-
tion of the nifedipine-sensitive component of charge movement, Q,,n,
required paired recordings in the same cell. To determine the stability of
the cell, we repeated the same pulse protocol 3-10 times within a control
period of 10-20 min. Reported Qns-V curves were from cells showing less
than 10% variation in Qmax during the control period. Nifedipine was
added to the bath solution in the range of 2-10 ,uM. In most cells, 2 ,uM
nifedipine was sufficient to block Qn, and higher concentrations did not
produce additional reduction in charge movement. However, 5-10 ,uM of
nifedipine was routinely used. We implemented two pulse protocols to
determine the Q-V relationship of a single cell. Protocol A consisted of a
25-ms test pulse P from holding potential -80 mV. To assist subtraction
of the linear components, pulse P was preceded by four hyperpolarizing
prepulses of amplitude P/4 (-P14 pulses) with a duration of 25 ms and an
interpulse period of 100 ms. An alternative protocol (protocol B) was
designed to inactivate Na+ and T-type Ca2+ channels and was therefore
used to assess the amount of immobilization-resistant charge movement.
Protocol B was similar to that used by Adams et al. (1990) and consisted
of a step from holding potential -80 mV to -20 mV for 1 s, then to -50
mV for 5 ms, then to test potential P for 25 ms, then to -50 mV for 30 ms,
and finally to the -80 mV holding potential. The -P14 pulses of 25-ms
duration and 500-ms interepisode duration followed this sequence from
-80 mV. Table 1 shows Boltzmann parameters obtained from a fit of
QON-V curves in five cells subjected to both protocols. The estimated Qmax'
V,/2, and k with either protocol A or protocol B were not significantly
different. Cell survival was longer with protocol A than with protocol B,
presumably because of the smaller number of pulses delivered by protocol
A. Because protocol A without -P14 was used to record current in most
instances, protocol A was used to compare charge movement in normal and
mutant myotubes. Boltzmann parameters obtained from a fit of QON-V or
QOFF-V curves in 13 normal cells by use of protocol A are indicated in
Table 1. QON and QOFF were obtained by integration of ON and OFF
currents, respectively. When necessary, a sloping baseline was fitted to the
end of the pulse current and extrapolated to the edge of the voltage step.
QON and QOFF were similar (see Table 1) in cells in which Cd2' effectively
blocked tail Ca2+ current. When this was not the case, QOFF became
contaminated, and QOEF > QON- Contamination by tail current was rarely
seen in mutant cells.
Intracellular Ca2+ transients
We measured intracellular Ca2+ by microfluorimetry of fura-2, using a
dual alternating-excitation wavelength illuminator attached to an inverted
microscope (Photon Technology International, London, Ontario, Canada).
Cells were loaded with 0.1 mM fura-2 AM for 20 min at room temperature.
The bath solution was the same for recording Ca2+ currents. The pipette
solution was (in mM) 140 Cs aspartate, 5 MgCl2, 0.1 EGTA, 10 MOPS-
CsOH; pH 7.2. After a whole-cell recording configuration was established,
a slit of -40 X 70 ,um was adjusted toward the center of the cell and away
from the patch pipette. Fluorescence emission was separated from excita-
tion by a dichroic cube with a 400-nm dichroic mirror and a 510/20
emission barrier filter. Emission ratios in response to alternate 340/380-nm
excitation were taken at a rate of 200 ratios/s. The 340/380 fluorescence
ratio at a given time during the Ca2+ transient was designated Rt and was
TABLE 1 Boltzmann parameters of charge movement in
normal cells
Protocol Qm. (nC/gF) VI/2 (mV) k (mV) n
Protocol A 7.85 ± 0.44 3.3 + 4.0 16.2 ± 0.4 5
Protocol B 7.73 + 0.38 3.0 ± 2.2 13.8 ± 0.6 5
QON 7.04 ± 0.54 -1.0 ± 1.0 13.8 + 0.8 13
QOFF 7.55 ± 0.63 -5.4 + 2.2 11.6 ± 0.7 13
Protocols A (without prepulse) and B (with prepulse) were described in
Materials and Methods and were performed in the same five normal cells.
QON and QOEF were obtained by integration of ON and OFF currents using
Protocol A in a separate group of 13 normal cells. Qm,, VI,2, and k (mean +
SE) correspond to averages of Boltzmann parameters fitted to each cell.
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divided by the resting fluorescence ratio before the stimulus, Rto. Because
the autofluorescence of cells was undetectable, the background fluores-
cence was measured in the same dish of dye-loaded cells from a field
without cells. The background fluorescence was subtracted from the 340-
and 380-nm fluorescence emission before the calculation of the emission
ratio. In control recordings, the amplitude of the Ca21 transient at the same
voltage was reduced two- to threefold and the decay time constant de-
creased ninefold when the pipette solution contained 5 mM EGTA. The
amplitude and decay of the Ca21 transient were approximately the same
when fura-2 (free acid) was loaded into the cell through the patch pipette
at a concentration of 0.1 mM.
[3H]PN 200-110 binding
Binding experiments were done as described by Pincon-Raymond et al.
(1985). Hind-limb muscles were dissected from normal and mutant mice.
Tissues were frozen in liquid nitrogen and stored at -80°C before use.
Muscles were thawed and immediately homogenized in -2 ml of ice-cold
300 mM sucrose, 20 mM Tris-Cl; pH 7.4. Homogenates were filtered
through four layers of moist cheesecloth, and the filtrate was immediately
used for binding experiments. Aliquots of homogenates were incubated
45-60 min at 25°C in 100 ,ul of a 50 mM Tris-Cl, pH 7.4, containing
0.12-0.36 nM (+)-[5-methyl-3H]-PN200-110 (85.8 Ci/mmol). The final
concentration of the homogenate was 1.2-1.9 mg of protein/ml, determined
by a Bradford assay (Bio-Rad, Richmond, CA) with bovine serum albumin
used as a standard. Samples were filtered with a cell harvester on Whatman
GF/C strip filters (Brandel, Gaithersburg, MD). Filters were washed twice
with double glass-distilled water and were counted with 4 ml of scintilla-
tion fluid after 12 h. Nonspecific binding was measured in the presence of
10 ,uM of unlabeled nifedipine, which is a competitive antagonist of
PN200-1 10. All experiments were made in duplicate, and counts were
averaged.
Chemicals and abbreviations
Deionized glass-distilled water was used in all solutions. All salts were
reagent grade. Nifedipine and Bay K 8644 were made as 10- and 5-mM
stocks in absolute ethanol and stored in light-resistant containers. Nifedi-
pine and TTX (tetrodotoxin) were obtained from Sigma Chemical Co. (St.
Louis, MO). Bay K8644 was from Calbiochem (La Jolla, CA). Fura-2 AM
was from Molecular Probes (Eugene, OR). (+)-[5-methyl-3H]-PN200-1 10
(85.8 Ci/mmol) was from New England Nuclear Research Products (Bos-
ton, MA). EGTA is ethyleneglycol-bis-(b-aminoethyl ether) N,N,N',N'-
tetra acetic acid; HEPES is N-2-hydroxyethyl piperazine-N'-2-ethanesul-
fonic acid; MOPS is 3-[N-morpholino]propane-sulfonic acid; TEA is
tetraethylammoniun.
Curve fitting
Curve fitting was done with the standard Marquardt-Levenberg algorithm
provided by either Sigmaplot (Jandel, San Rafael, CA) or pClamp (Axon
Instruments). The relationship between charge movement (Q) or L-type
current conductance (G) and pulse potential was fitted by a Boltzmann
equation expressed as follows: A = Amax/(1 + exp(-(V - VI/2)/k)). Amax
is the maximum amount of movable charge (Qmax) or the maximum
conductance (Gmax), V1/2 is the potential at which A = Amax/2, and k is the
slope factor. To determine the cell-to-cell variability, we fitted a Boltz-
mann curve for each cell separately. The mean ± SE of averages of
Boltzmann parameters fitted separately to each cell are shown in Tables 1
and 2 and the text. In some cases we made a Boltzmann fit to the
population average Q-V curve obtained by pooling data from many cells
(see the solid curves in Figs. 6 and 7). The time constant T, describing
activation of Ca2+ current was obtained from a fit of pulse current at each
voltage according to I(t) = K[(l - exp(-t/Tr)exp(-t/T2), where K is
constant and T2 describes inactivation. All averages are presented as
mean ± SE.
RESULTS
Fig. lA shows two distinct Ca21 channel types in freshly
dissociated intercostal myotubes from normal fetal 18-day-
old mice. The charge carrier was 10 mM Ba2+, but other
recordings described below were made in 10 mM Ca2 .
Test pulses of 300 ms from a holding potential of -80 mV
revealed a low-voltage-activated transient component with a
time to peak of -20 ms at -10 mV and a high-voltage-
activated sustained component. Previous studies identified
the transient component as a T-type current and the sus-
tained component as a DHP-sensitive L-type current (Cog-
nard et al., 1986; Beam and Knudson, 1988). We further
tested for the presence of these two components by analyz-
ing the voltage dependence of current measured either at the
peak or at the end of the 300-ms test pulse (Fig. 1 B). The
lowest voltage that evoked a T-type current was -40 mV,
whereas that for the L-type current was -10 mV. Similar
measurements for f31-null myotubes are shown in Fig. 1 C
and D. In the mutant myotube, the density of sustained
current (hereafter called Ipn.11) was much smaller than the
density of L-type current of normal cells (see below). In
TABLE 2 Boltzmann parameters of charge movement and Ba2+ conductance in normal and P1 null skeletal muscle cells
Normal Mutant
Parameters Qmax (nC/,lF) VI/2 (mV) k (mV) n Qmax (nC/IF) VI12 (mV) k (mV) n Mutant/Normal
Qtotal 6.94 ± 0.61 -1.50 ± 1.13 13.19 ± 0.66 19 2.54 ± 0.20 -9.32 ± 1.75 8.75 ± 0.62 21 0.37
Qns 2.84 ± 0.86 -2.24 ± 2.18 9.74 ± 1.05 6 1.14 ± 0.24 -12.88 ± 6.62 4.30 ± 1.65 5 0.40
Normalized Qn - -2.96 9.46 6 _ -15.65 8.52 5 -
Gmax(pS/pF) Gmax(PS/PF)
GBa 161.61 ± 8.93 -0.20 ± 0.83 3.96 ± 0.30 18 17.88 ± 1.34 4.88 ± 1.31 6.48 ± 0.43 17 0.11
Normalized GBa -0.62 4.29 18 4.38 6.72 17 -
Qn,IQtotal 0.41 - - - 0.45 - - -
GBa/Qns 56.90 - - - 15.68 - - -
Qmax' V1/2, and k (mean ± SE) Of Qtotal, Qns, and GBa correspond to averages of Boltzmann parameters fitted to the Q-V and G-V curves of each cell. V1/2
and k of normalized Qns and GBa correspond to Boltzmann parameters fitted to the average Q/Qmax-V and G/Gmax-V curves constructed by pooling data
from all cells.
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A.
FIGURE 1 Ba2+ currents recorded
in normal (A) and mutant (C) myo-
tubes. Voltage-clamp records during
300-ms depolarizing steps from hold-
ing potential -80 mV to the indi-
cated potential. The capacitance of
normal and mutant myotubes was
336 and 432 pF, respectively. Volt-
age dependence of the average Ba2+
current density measured at the end
of the pulse (0, A) and at the peak
(0, A) in normal (B; n = 18) and
mutant (D; n = 17) myotubes.
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contrast, the T-type current was, on the average, approxi-
mately equal in density to the T-type current of normal cells.
The peak T-type current in response to a test pulse to -20
mV from holding potential -80 mV was 1.81 ± 0.21 pA/pF
in normal (n = 18) and 1.76 ± 0.18 pA/pF in mutant (n =
17) cells. Both L-type and T-type currents were invariably
present in 94 normal and 92 mutant cells analyzed.
A separation of T-type and L-type currents was possible
by changing the holding potential from -80 to -40 mV, as
shown in Fig. 2A and C, for which 10 mM Ca21 was used
as the charge carrier. The -40-mV holding potential elim-
inated the T-type current of normal and mutant cells, but the
normal L-type (Fig. 2 A) or I'null (Fig. 2 C) components
were unchanged. I-V curves measured at the end of the
300-ms test pulse from the two holding potentials are shown
in Fig. 2 B and D for normal and mutant cells, respectively.
In both populations there was a small amount of T-type
current that remained not inactivated at the end of the pulse
when the holding potential was -80 mV but not when the
holding potential was -40 mV. However, the I-V curves
were invariant with holding potential when the test potential
was positive. This indicated that there was little if any
contamination by the T-type Ca2+ current in this voltage
range. Based on these considerations, the normal L-type
Ca2+ current density at +20 mV was 5.20 ± 0.38 (n = 14),
and I'nuI1 was 0.41 ± 0.04 pA/pF (n = 12). Fig. 3 shows
that the GCa-V curve for the I'nU.1 current was shifted toward
positive potentials (-5.5 mV at the midpoint) and was less
steep than that for the L-type current of normal cells. The
same phenomenon was observed when 10 mM Ba2+ was
used as the charge carrier (see Table 2). The decrease in
current amplitude and the positive shift of the G-V curve
were similar to observations made in heterologous expres-
sion systems when the als subunit was expressed in the
absence of PI3 (Lory et al, 1992). However, the magnitude of
the shift in ,(31-null cells is uncertain because V1/2 varied
with the extrapolated Ca2+ current reversal potential.
To establish the relationship between Inl.u and the nor-
mal L-type current, we determined the sensitivity of I'null to
nifedipine and Bay K 8644. Fig. 4A shows Ba2+ current at
a test potential that activated both T-type and Ionull currents
in a mutant cell, during a control run and after a bath
application of 5 ,uM nifedipine. Currents from a separate
mutant cell during a control run and after bath application of
5 ,uM Bay K 8644 are shown in Fig. 4 C. The inhibitory
effect of nifedipine and the stimulatory effect of Bay K
8644 were much more pronounced on the current at the end
of the pulse than on the peak current dominated by the
T-type current. I-V curves for end-of-pulse current are
shown before and after bath application of nifedipine (Fig.
C.
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-10 mV
FIGURE 2 Ca2+ currents in normal
(A) and mutant (C) myotubes. Voltage-
clamp records during 300-ms depolar-
izing steps from holding potential -80
mV (0, A) or -40 mV (-, A) to the
indicated potential. The capacitance of
normal and mutant myotubes was 417
and 489 pF, respectively. Voltage de-
pendence of the average Ca21 current
density measured at the end of the
pulse from a holding of potential of
-80 mV (0, A) or -40 mV (0, A) in
normal (B; n = 14) and mutant (D; n =
12) myotubes.
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reduced to background levels by nifedipine,
T-type current at -30 mV was unchanged. In
K 8644 increased 13nuIl -2.5-fold with no e
T-type current. These results indicated that Inu
to DHPs and therefore is an L-type current. Av
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FIGURE 3 Voltage dependence of the normalized Ca
measured from holding potential -40 mV in normal (A
mutant (0, n = 12) myotubes. Values of Boltzmann parai
shown by the curves are V 12 = 6.43 mV and V112 = 11.8:
mV and k = 7.63 mV, for normal and mutant, respective
20 mV was als subunit is expressed in the absence of (Varadi et al.,
whereas the 1991; Lory et al., 1992).
contrast, Bay The effect of DHPs, the reduced current density, and the
-ffect on the positive shift of the I-V curve suggested that IpnuI1 could
is sensitive originate from a dihrodropyridine complex lacking (3,. The
4oreover, the presence of PIl either increases (Lacerda et al., 1991; Singer
is more pro- et al., 1991; Varadi et al., 1991; Wei et al., 1991; Lory et al.,
'pe current at 1992), decreases (Perez-Garcia et al., 1995) or has no effect
shown). The on (Itagaki et al., 1992; Lory et al., 1993) the activation rate
insistent with of the al current, depending on the expression system and
ms when the al subtype. Therefore, we compared the kinetics of ',{null
and normal L-type currents. Fig. 5 A shows scaled traces of
normal L-type (triangles) and Ipnull (circles) Ca2+ currents
activated by a test pulse to +10 mV. A pulse duration of
750 ms and a holding potential of -40 mV were necessary
t s for observation of L-type current inactivation and elimina-
tion of the T-type current. IPnull activated faster and inacti-
vated more slowly than the L-type current of normal cells.
The solid curves in Fig. 5 A correspond to a fit using an
equation derived from a linear kinetic scheme with a single
activation and inactivation step (see Materials and Meth-
ods). This equation adequately fitted the pulse current over
a wide range of test potentials. Fig. 5 B shows time con-
40 60 stants for activation of normal L-type and Ipnull currents
obtained by a fit of traces at each test potential. 'i.null
activated in a voltage-dependent manner, and the activation
,2+ conductance time constant was significantly smaller than that of the
k, n =14) and
meters olfthe fit L-type current of normal cells over a wide range of positive
3 mV; k = 3.95 test potentials. This result was consistent with the observa-
ly. tion in heterologous expression systems showing that I13
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0-
. _ 6110Z~~ +10 mV
100 ms
FIGURE 4 Ba2+ currents in re-
sponse to a 300-ms depolarizing pulse
from holding potential -80 mV to
+10 mV in control (0) and 10 min
after addition of 5 ,uM (0) nifedipine
(A) or 5 ,uM Bay K 8644 (C). The
capacitance of the myotubes was 614
and 590 pF in A and C, respectively.
Voltage dependence of the average
Ba21 current density measured at the
end of the pulse in control and 10 min
after addition of nifedipine (B; n = 9)
or Bay K 8644 (D; n = 7).
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slowed the activation of the Ca21 current produced by alc
subunit in HEK cells (Perez-Garcia et al., 1995) and dis-
agreed with other studies showing that PIl accelerated the
kinetics of alc subunit in oocytes (Singer et al., 1991; Wei
et al., 1991) and of als in L cells (Lacerda et al., 1991;
Varadi et al., 1991; Lory et al., 1992).
Fig. 6 shows recordings of nonlinear charge movement in
a normal and a mutant myotube of similar cell capacitance
obtained with protocol A described in Materials and Meth-
ods. At -40 mV and more negative test potentials, charge
movement was not detectable. With test potentials more
positive than -40 mV, ON and OFF components of charge
movement became progressively larger, and they saturated
at test potentials more positive than +30 mV. Some records
showed a small nonlinear leak component, which presum-
ably was due to residual outward current (see Bean and
Rios, 1989). The most obvious feature of charge movement
in the mutant cells was the reduction in magnitude (Fig. 6
B). After they were normalized for uncompensated cell
capacitance, the Q-V curves of 19 normal and 21 mutant
cells were pooled. Fig. 6 C shows that the population
average Q-V curve could be adequately fitted by a single
Boltzmann equation with parameters decribed in the figure
legend for both groups. In normal cells the fitted Qmax
agreed well with previous reports in either freshly dissoci-
ated (Beam and Knudson, 1988; Strube et al., 1992) or
cultured (Garcia et al., 1994) myotubes. The Qmax of mutant
cells was approximately 2.8-fold lower than that of normal
cells. The threshold for movement of the first charges oc-
curred at approximately the same potential in both prepa-
rations, but saturation occurred earlier in mutant cells. Con-
sequently, the Q-V curve of mutant myotubes was shifted
-8 mV toward negative potentials relative to the Q-V curve
of normal myotubes. Averages of Boltzmann parameters
obtained by fitting each cell separately are shown in Table
2. A paired t-test of the average Qmax, V112, and k (normal
versus mutant) indicated that the difference was significant
(p < 0.001) for all parameters.
Because protocol A may result in charge movements
from several different channel types, we determined the
amount of nifedipine-sensitive charges in both preparations.
Previous studies indicated that the DHP-sensitive compo-
nent of charge movement originates from the voltage sensor
of E-C coupling and from gating currents of L-type Ca2+
channels (Rios and Brum, 1987; Pizarro et al., 1988; Adams
et al., 1990). To determine the amount of nifedipine-sensi-
tive charges, we subjected the same cell during the control
period to a minimum of three runs of eleven test pulses from
-50 to +50 mV and later to a minimum three runs follow-
ing bath application of 2-10 ,tM nifedipine (Fig. 7 A and B).
The nifedipine-sensitive component was obtained by sub-
traction at each test potential in each cell, and the average is
shown in Fig. 7 C. Boltzmann parameters fitted to the
population average Qns-V curves are given in the figure
legend. Similar to the Q,Otal-V curve, the Qns-V curve of
mutant cells had a reduced Qmax' and there was a significant
shift in V112 toward negative potentials. These differences
were also apparent in Table 2, corresponding to averages of
A. C.
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FIGURE 5 (A) Scaled traces of Ca21 current from
a normal (A) and a mutant (-) myotube in response
to a 750-ms depolarizing pulse from a holding poten-
tial of -40 mV to +10 mV. The solid curves corre-
spond to a fit using the biexponential equation for I(t)
described in Materials and Methods with K = -1.29
pA, T, = 54.7 ms, T2 = 750 ms for normal and K =
-1.07 pA, T, = 19.9 ms, T2 = 1416 ms for mutant.
(B) Time constant for current activation for normal
(A) and mutant (-) myotubes. Numbers near symbols
indicate the number of cells. Asterisks indicate time
constants of normal and mutant cells found to be
significantly different to p < 0.005 according to a
paired t-test.
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Boltzmann parameters fitted separately to each cell. Table 2
shows that the proportion of nifedipine-sensitive charge
movement relative to the total charge movement was ap-
proximately the same in normal and mutant cells (Qns(max)/
Qtotal(max) 0.40). Thus, charge movements appeared to be
equally sensitive to nifedipine in both groups.
A lower density of Qns in mutant myotubes could origi-
nate from a lower density of DHP receptors in the cell
membrane. To determine whether this was the case, we
performed radioligand binding analysis in homogenates of
normal and mutant skeletal muscles, using the high-affinity
DHP [3H]PN 200-110. In all cases (Table 3) we observed
a saturable and specific binding of the radio label in a range
of concentration from 0.12 to 36 nM. Scatchard represen-
tations resulted in a straight line from which Bmax and Kd
were estimated. In mutant muscle, [3H]PN 200-110 maxi-
mum binding site density (Bmax) was reduced -3.9-fold,
and the dissociation constant (Kd) was -3.6-fold higher.
The decrease in Bmax in the [31-null muscle agreed with
results in heterologous systems (Lacerda et al., 1991; Varadi
et al., 1991; Wei et al., 1991; Lory et al., 1992; Nishimura
et al., 1993; Perez-Garcia et al., 1995). The decrease in DHP
binding site density in the homogenate of mutant muscle
agreed with the decrease in Qns, thus confirming a lower
density of membrane-bound DHP receptors.
We previously found that intracellular Ca2+ transients
could not be elicited by action potentials in ,13-null cells
(Gregg et al., 1996). We therefore determined the relation-
ship between the L-type Ca2+ currents and the elicited Ca2+
30 40 50 60
transients. A test pulse of variable amplitude and a duration
of 50 ms was applied to normal cells. The same pulse with
a duration of 500 ms was applied to mutant cells to com-
pensate for the fact that Ignull had a much lower density. A
holding potential of -40 mV was used in all cases. Between
subsequent pulses there was a resting period of 40 s. In the
normal cell (Fig. 8A) the onset of the Ca2+ transient was
instantaneous with the onset of the test pulse. The peak
fluorescence was followed by a decay that had a t112 of
0.3-0.5 s, consistent with previous reports (Grouselle et al.,
1991; Garcia and Beam, 1994; Strube et al., 1994). The
Ca2+ current and the Ca2+ transient activated over the same
range of pulse potential. However, at depolarizations more
positive than +20 mV the peak of the Ca2+ transient
remained constant, whereas the Ca2+ current decreased as
the test pulse approached the reversal potential. The con-
stancy of the Ca2+ transient, in the face of a decreasing
Ca2+ current, indicated that a voltage-dependent rather than
a Ca2+ entry mechanism participated in the generation of
Ca2+ transients, in agreement with previous observations
(Cognard et al., 1992, 1993; Garcia et al., 1994; Strube et
al., 1994). Caffeine induced a Ca2+ transient much larger
than that induced by cell depolarization (not shown). There-
fore, the constancy of the transient at positive potentials did
not reflect dye saturation. Unlike in normal cells, Ca2+
transients could not be elicited in mutant cells at any test
potential (Fig. 8 C). Fig. 9 shows the voltage dependence of
the peak of the Ca2+ transient, and this is compared with the
voltage dependence of the integral of the Ca2+ current in the
.
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FIGURE 6 Asymmetric currents
produced by intramembrane charge
movements in a normal (A) and a mu-
tant (B) myotube. Voltage-clamp traces
were recorded during 25-ms depolariz-
ing steps from holding potential -80
mV to the indicated potentials. The ca-
pacitance of normal and mutant myo-
tubes was 321 and 382 pF, respectively.
(C) Q-V curves of normal (A, n = 19)
and mutant (-, n = 21) myotubes.
Curves correspond to a Boltzmann fit
of the mean with parameters Qmax =
6.55 and Qmax = 2.43 nC//F; VU12 =
-2.33 and VU12 = -9.25 mV; k =
12.85 and k = 9.49 mV for normal and
mutant, respectively.
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same cells. In agreement with previous results in myotubes
in culture (Garcia et al., 1994), the amplitude of the Ca21
transients saturated at potentials more positive than +40
mV. A Boltzmann relationship fitted to the Ca2+ transient is
shown by the curve and resulted in a fitted Rt/Rto(max) =
2.36, V112 = 2.1 mV, and k = 8.6 mV. The VV2 and k were
within the range reported for normal myotubes in culture
(Garcia and Beam, 1994; Garcia et al., 1994). In the case of
mutant cells, there was a much larger entry of Ca2+ into the
cell because of the longer pulse duration. However, Ca2+
entry did not trigger a Ca21 transient.
Because the absence of a Ca2+ transient in f31-null cells
could be due to insufficient storage of Ca2+ in the sarco-
plasmic reticulum, we performed intracellular Ca2+ mea-
surements in the presence of caffeine (Fig. 10). Bath appli-
cation of 5 mM caffeine to a mutant cell resulted in a robust
Ca2+ transient that lasted for several seconds. Furthermore,
preapplication of 1 ,tM thapsigargin for 10 min eliminated
the caffeine-induced Ca2+ transient. These data indicated
that caffeine caused a release of Ca2+ from a thapsigargin-
sensitive store, presumably the sarcoplasmic reticulum, and
that the Ca2+ storage and release capacities of mutant cells
were not impaired.
DISCUSSION
,p1-null cells fail to contract in response to electrical stim-
ulation despite the presence of a normal action potential and
a caffeine-induced contracture, suggesting that E-C cou-
pling is impaired (Gregg et al., 1996). In the present study
we investigated the events that are known to control exci-
tation-Ca2+ release from normal skeletal muscle cells and
that might lead to the failure of Ca2+ release in mutant cells.
The significant findings of this study are the following: 1)
The presence of an L-type current in mutant cells identified
by its high voltage threshold, slow inactivation, and sensi-
tivity to DHP agonists and antagonists. The L-type current
density of mutant cells is reduced - 13-fold compared with
normal; 2) The presence of charge movements in mutant
cells that are sensitive to nifedipine. The density of Q.. of
mutant cells is reduced -2.5-fold, and the V,12 of the Qns-V
curve is - 10 mV more negative than that of normal cells; 3)
The -3.9-fold reduction in the maximum number of
[3H]PN200-1 10 binding sites in homogenates of mutant
skeletal muscle; 4) The absence of a depolarization-induced
Ca2+ transient in mutant cells despite the presence of thap-
sigargin- and caffeine-sensitive Ca2+ storage and release
2538 Biophysical Jolurnal
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FIGURE 7 Q-V curves of normal
(A; n = 6) and mutant (B; n = 5)
myotubes during control (0, A) and S
min after addition of nifedipine (-,
A). (C) Qns-V curves of normal (A,
n = 6) and mutant (-, n = 5) myo-
tubes. For each cell, Qns was calcu-
lated by subtracting the value of Q
obtained after addition of nifedipine
from the value of Q obtained in con-
trol at each voltage. Curves corre-
spond to a Boltzmann fit of the mean
with parameters Qmax = 2.89 and
Qmax = 1.12 nC/tkF; V,/2 = -2.43
and V,,2 = -11.25 mV; k = 9.7 and
k = 8.72 mV for normal and mutant,
respectively.
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capacities. Taken together, these observations suggest that
mutant cells have a low density of functional voltage sen-
sors and that these voltage sensors are unable to support E-C
coupling.
TABLE 3 Binding parameters of [3H]PN200-1 10 to skeletal
muscle homogenates from normal and mutant mice
Bmax (fmollmg) Kd (nM) n
Normal
18 0.19 5
19 0.42 5
24 0.53 5
46 0.67 5
Mean + SE
27 ± 6 0.45 + 0.10 -
Mutant
5 1.72 8
5 1.59 8
11 1.51 8
Mean + SE
7 ± 2 1.61 + 0.06 -
Leg muscles from the indicated number of fetuses were pooled and
homogenized as described in Materials and Methods. Binding parameters
BmaX and Kd were obtained from a straight line fitted to a Scatchard
representation of specific [3H]PN 200-110 binding in the concentration
range of 0.12-36 nM. Parameters from separated experiments were
averaged.
20 40 60
The fact that differs from the normal L-type Ca2+
current not only in current density but also in kinetics and
other properties raises the question of the origin of If3nuIll
The slower inactivation, higher DHP sensitivity, and posi-
tive shift of the I-V curve suggest that Ig3null may be a
down-regulated current produced by alsya2/6 complexes,
as occurs when a, is expressed in the absence of I3 in
heterologous systems (Singer et al., 1991; Varadi et al.,
1991; Lory et al., 1992, 1993). However, I>null could be
unrelated to als, because studies in als-deficient dysgenic
myotubes describe a Ca2+ current, Idys, that shares similar-
ities to In.1 (Adams and Beam, 1989). For example, I,3ul
and Idys have a similar peak current density, which in 10
mM Ca2+ amounts to 0.61 ± 0.08 pA/pF for Idys (Adams
and Beam, 1989) and to 0.41 ± 0.04 for I'null. An internal
control for this comparison is provided by the peak T-type
current, which has identical density in either dysgenic or
f3I-null myotubes (1.62 ± 0.17 pA/pF for dysgenic cells and
1.76 ± 0.18 pA/pF for 13,-null cells). Furthermore, I'3null,
like Idys, is more sensitive to Bay K 8644 and activates
faster than the normal L-type current. However, there are
significant differences between Ipnul and Idys reflected in
the I-V curves. Idys is shifted to the left of the I-V curve of
normal cells, whereas I'nuIl is slightly right shifted. This is
a rather significant difference, implying that the mecha-
nisms of voltage-dependent activation of Idys and I'3null are
--L-
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FIGURE 8 Simultaneous recordings of Ca21 transients and Ca21 currents under voltage clamp in a normal (A, B) and a mutant (C, D) myotube. Ca2+
transients (A, C) and Ca21 currents (B, D) were elicited by a test pulse from holding potential of -40 mV to the indicated potential. The test pulse duration
was 50 ms in normal and 500 ms in mutant. The capacitance of normal and mutant myotubes was 473 and 490 pF, respectively. P indicates the onset of
the test pulse.
different and may represent different arrangements of Ca2+
channel subunits. A comparison of I13null and Ca2+ currents
obtained by overexpression of als in 813-null cells should
establish whether I'nu,,, like Idys, represents an embryonic
current unrelated to skeletal-type DHP complexes or
whether I'null is the functional expression of an alsy2/8
complex.
The interpretation of charge movements was facilitated
by the observation that Qmna was resistant to immobilization
by a prepulse and thus unlikely to originate from either Na+
channels or T-type Ca2+ channels (Table 1). Protocol B
included a long prepulse to -20 mV and a 5-ms repolar-
ization to -50 mV before the test pulse. In Ca2+ recording
solutions containing 10 mM Na+, the Na+ current and the
T-type Ca2+ current inactivated completely during the pre-
pulse to -20 mV. During the test pulse, more than 70% of
INa+ remained inactivated. Evidently, there was some re-
covery of INa+ during the 5-ms repolarization to -50 mV.
However, the repolarizing period could not be made shorter,
as doing so also prevented recovery of nifedipine-sensitive
charges moved during the prepulse. In contrast, the T-type
current remained inactivated during the test pulse of proto-
col B. If Qmax obtained by protocol A were severely con-
taminated by Na+ channel gating current, QON of protocol
A should have been larger than QON of protocol B because
of charge immobilization during protocol B. This was not
observed (see Table 1), and therefore protocol A was suf-
ficient to detect the bulk of the immobilization-resistant
component of charge movements in these cells. The fact that
protocol A and protocol B detected similar amounts of
nonlinear charge movements agrees with the conclusions
reached that in adult skeletal muscle Na+-channel density is
low and therefore that the contribution to detectable charge
movements is minor (Almers, 1978). Further, a comparison
of charge movements in fetal cardiac cells by use of proto-
cols with and without prepulses did not detect a significant
immobilization-sensitive component (Field et al., 1988).
We are not aware of a similar comparison for fetal skeletal
muscle besides the data provided here. However, skeletal
myotubes in culture do have a significant amount of immo-
bilization-sensitive component (Adams et al., 1990).
The Qtotal(max) of normal cells measured here (6.9 ± 0.61
nC/,F) agreed well with measurements in acutely dissoci-
ated 1-5-day-old rat myotubes (6.0 ± 1.7 nC/,F; Beam and
Knudson, 1988); acutely dissociated 18-day-old dysgenic
heterozygous (+/mdg) fetal mouse myotubes (6.3 ± 1.4
nC/,lF; Shimahara et al., 1992); and 7-11-day-old mouse
myotubes in culture (5.1 ± 0.9 nC/,F; Garcia et al., 1994).
On the other hand, Qtotal(max) of f,3-null cells (2.54 ± 0.2
nC/,uF) was slightly larger than that of acutely dissociated
18-day-old dysgenic homozygous (mdg/mdg) fetal mouse
myotubes (1.7 0.3 nC/,uF; Shimahara et al., 1992) or
approximately equal to that of mdg/mdg myotubes in culture
(2.5 ± 0.8 nC/gF; Adams et al., 1990) when the Qtmal(max)
of cultures of normal cells run in parallel was 7.9 ± 1.4
nC/,uF (Adams et al., 1990). Based on the numerical simi-
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either a developmental form of a I such as the reported
cardiac isoform (Chaudhari and Beam, 1993) or the two-
A Normal motif isoform (Malouf et al., 1992) or from the presence of
* Mutant T Idys but not of als, which is the isoform that specifically
confers skeletal type E-C coupling to the developing skel-
etal muscle cell (Tanabe et al., 1990b). In this respect, it
should be mentioned that Qns has been reported in cultures
of dysgenic myotubes (B. A. Adams, personal communica-
tion) but not in freshly dissociated cells (Shimahara et al.,
1990, 1992). Although the present results could not identify
the source of Qns in 131-null cells, they do not exclude the
possibility that Q., may originate from als5ya2/ complexes
present in the plasma membrane in amounts much lower
40 -20 0 20 40 60 than in normal cells and that these complexes without 13l
Potential (mV) fail to initiate E-C coupling.
-40 -20 0 20 40 60 The reduction in [3H]PN200- 110 binding to microsomes
, I , I I I I , of f1,-null muscle and the reduction in Qns suggest that the
density of functional als subunits or alsya2/5 complexes in
the surface or transverse tubular membranes of mutant cells
is reduced. A reduction in plasma membrane als agrees
with the observation that expression of 01 in L cells or 182a
in HEK 293 cells increases the amount of immunodetect-
able als or alc, respectively, located in the plasma mem-
brane of transfected cells (Krizanova et al., 1995; Chien et
al., 1995). Also, a reduction in the density of alc subunits
expressed in the membrane of HEK 292 cells when alc is
expressed in absence of 131a or 133 has been deduced from the
decrease in the density of charge movements of the ex-
pressed Ca2+ channels (Josephson and Varadi, 1996; Kamp
et al., 1996). However, with regard to the observed - 13-
fold decrease in Ca2+ current of mutant cells, the reduction
a2+ currents and Ca2+ transients recorded in normal (A, in plasma membrane als may account only for a -2.5-to-
itant (0, n = 8) myotubes. (A) The peak amplitude of the 3.9-fold reduction in L-type Ca2+ current, because these are
plotted as a function of the test potential. Test pulses were the extent of the reduction of Qns(max) and Bmax in these
40 mV and had a duration of 50 ms in normal cells and 500 cells. The additional
-5.2-to-3.3-fold reduction in L-type
lAs. The sigmoidal curve corresponds to a Boltzmann fit of Ca2+ current must thus be explained as being due to differ-
scence ratio of normal cells with parameters Rt/Rto(max) =
2.1 mV; k = 8.6 mV. (B) Integral of Ca21 current recorded ent mechanisms. We have considered the possibility that PI
transient in the same cells. may affect the G-V and Q-V curves of the skeletal DHP
receptor differently. Previous studies suggest that intermo-
lecular coupling between charge movements and opening of
-n the charge movements of dysgenic and 131- the pore is facilitated by the f3 subunit because the Gmax/
Is, it could be proposed that QtotaI(max) may not Qmax ratio in much higher in cells expressing alc and 12a or
t to support a voltage-dependent transduction alc and 613a than in cells expressing aic alone (Neely et al.,
f E-C coupling in the 31-null cell. We believe 1993; Kamp et al., 1996). Inasmuch as GBa/QnS was much
lanation is unlikely because measurements in larger in normal than in mutant cells (Table 2), I)3nu1l could
)ciated normal 14-day-old fetal myotubes indi- display less intramolecular coupling than could the normal
:al(max) or Qns(max) is the same as or smaller than L-type current. Thus, at the same voltage, opening of IunuI
-ters in 131-null cells, yet 100% of the 14-day- channels would be less probable than the opening of normal
elicit Ca2+ transients in response to a depo- L-type channels. This possibility can be investigated di-
d -50% of these responses are independent of rectly by cell-attached patch-clamp recording or by fusion
(Strube at al., 1992, 1994). Thus the reduction of transverse tubular membranes to planar bilayers (Affolter
)vement per se, to the extent observed in P,3-null and Coronado, 1985). Also, the 13 subunit could be critically
t explain the absence of a voltage-activated involved in the arrangements of DHP receptors into arrays
nt. It is conceivable that some inherent property of tetrads in the transverse tubular membrane. When this
Dvement may be different in mutant cells, and arrangement is disrupted, the L-type Ca2+ current is dras-
ount for the uncoupling. This would be the case tically reduced, but charge movements are almost normal
null cells originated from charge movement of (Takekura et al., 1995; Nakai et al., 1996). Finally, it must
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FIGURE 10 Ca21 transient induced in a ,o F
mutant myotube by 5 mM caffeine in the 3 3
absence (A) and presence (B) of 1 ,tM X 2
thapsigargin. 22K
Caffeine (5mM) Caffeine (5mM)
5sI
be emphasized that in muscle cells the interpretation of the
G/Q ratio may not be so straightforward as in heterologous
expression systems. It has been argued that in skeletal
muscle the a, isoform that generates the L-type Ca2+ cur-
rent is functionally different from the isoform that initiates
E-C coupling (Pizarro et al., 1988; De Jongh et al., 1989;
Bois et al., 1991). If this is ultimately the case, measure-
ments of G and Q in muscle cells may not reflect properties
of a single population of DHP receptors with the same
functional properties. The role of ,B subunits in modulating
DHP receptor function as well as the number of al subunits
in the membrane can now be elucidated in the homologous
expression system provided by the p31-null skeletal muscle
cells.
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